During the past decade, PROVITA 2000 Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "PROVITA 2000 Medical Center" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "PROVITA 2000 Medical Center" are "Prostate Cancer" (3 trials), "Clear Cell Renal Carcinoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "PROVITA 2000 Medical Center" in a lesser frequency.

Most popular intervention types in "PROVITA 2000 Medical Center" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (2 trials), "Goserelin acetate" (2 trials), "ABR-217620/naptumomab estafenatox" (1 trials), "Degarelix 160 mg / Degarelix 160 mg" (1 trials) and "Degarelix 80 mg / Degarelix 80 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "PROVITA 2000 Medical Center" are 3 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "PROVITA 2000 Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in PROVITA 2000 Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in PROVITA 2000 Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".